11200 |
CHECKPOINT KINASE 2 |
CHEK2 |
CDS1 |
CHK2 |
HuCds1 |
LFS2 |
PP1425 |
RAD53 |
hCds1 |
604373 |
16627 |
ENSG00000183765 |
OTTHUMG00000151023 |
O96017 |
CHK2_HUMAN |
SERINE/THREONINE-PROTEIN KINASE CHK2 (EC 2.7.1.37) (CDS1). [SOURCE:UNIPROT/SWISSPROT;ACC:O96017] |
SERINE/THREONINE-PROTEIN KINASE CHK2 |
Cds1 homolog |
CHK2 checkpoint homolog |
bA444G7 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Uniprot Status | Swiss-Prot |
Interpro Acc | IPR002290 |
Uniprot Evidence | 1: Evidence at protein level |
Human Readable Name | KINASE |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
Interpro Type | Domain |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.1 |
Gene Biotype | PROTEIN_CODING |
KINASE |
SERINE THREONINE KINASE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
ENZYME |
TRANSCRIPTION FACTOR |
CHEK2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
SERINE/THREONINE-PROTEIN KINASE CHK2 (EC 2.7.1.37) (CDS1). [SOURCE:UNIPROT/SWISSPROT;ACC:O96017] | Description |
CHEK2 | Display Id |
ENSG00000183765 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
CHEK2 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.1 |
CHK2_HUMAN | Uniprot Id |
11200 | Entrez Gene Id |
O96017 | Uniprot Accession |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Uniprot Status | Swiss-Prot |
Human Readable Name | DRUGGABLE GENOME |
KINASE, DRUGGABLE GENOME |
ENSG00000183765 | Gene Symbol |
CHEK2 | Ensembl Id |
DRUGGABLE GENOME |
ENSG00000183765 | Ensembl Gene ID |
bA444G7 | Human Protein Atlas Gene Synonym |
CDS1 | Human Protein Atlas Gene Synonym |
ENZYME |
CDS1 | GO Gene Synonym |
CHK2 | GO Gene Synonym |
RAD53 | GO Gene Synonym |
SERINE THREONINE KINASE |
CHEK2 | Gene Symbol |
CLINICALLY ACTIONABLE |
11200 | Gene ID |
CDS1 | dGene Synonym |
CHK2 | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
Serine/threonine-protein kinase Chk2 | Gene Name |
O96017 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |